quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:56:50·24d
SECFiling
TherapeuticsMD Inc. logo

TherapeuticsMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

TXMD· TherapeuticsMD Inc.
Health Care
Original source

Companies

  • TXMD
    TherapeuticsMD Inc.
    Health Care

Recent analyst ratings

  • Mar 11UpdateHC Wainwright & Co.$2.50
  • Nov 12UpdateHC Wainwright & Co.$3.00

Related

  • SEC23d
    Amendment: SEC Form 10-K/A filed by TherapeuticsMD Inc.
  • SEC23d
    SEC Form NT 10-K filed by TherapeuticsMD Inc.
  • SEC24d
    SEC Form 10-K filed by TherapeuticsMD Inc.
  • PR24d
    TherapeuticsMD Announces Full Year 2025 Financial Results
  • INSIDER115d
    Director Thompson Tommy G bought $14,031 worth of shares (8,400 units at $1.67), increasing direct ownership by 57% to 23,179 units (SEC Form 4)
  • SEC128d
    TherapeuticsMD Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
  • SEC162d
    TherapeuticsMD Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC162d
    SEC Form 10-Q filed by TherapeuticsMD Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022